ATE42548T1 - Verwendung einiger 2-(2-(4-phenyl-1piperazinyl)|thyl>-1h-naphth-(1,2-d)imidazolderivate und deren pharmazeutisch annehmbare salze zur herstellung eines medikaments zur behandlung cardiovaskulaerer erkrankungen. - Google Patents

Verwendung einiger 2-(2-(4-phenyl-1piperazinyl)|thyl>-1h-naphth-(1,2-d)imidazolderivate und deren pharmazeutisch annehmbare salze zur herstellung eines medikaments zur behandlung cardiovaskulaerer erkrankungen.

Info

Publication number: ATE42548T1
Authority: AT; Austria
Prior art keywords: phenyl; pharmaceutically acceptable; naphth; thyl; medication
Prior art date: 1984-02-07

Application number

AT85100667T

Other languages

English (en)

Inventor

Emilio Toja

Domenico Barone

Emiliana Baldoli

Original Assignee

Lepetit Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-02-07

Filing date

1985-01-23

Publication date

1989-05-15

1985-01-23 Application filed by Lepetit Spa filed Critical Lepetit Spa

1989-05-15 Application granted granted Critical

1989-05-15 Publication of ATE42548T1 publication Critical patent/ATE42548T1/de

Links

208000024172 Cardiovascular disease Diseases 0.000 title 1
229940079593 drug Drugs 0.000 title 1
239000003814 drug Substances 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
KKAMJECDKNIUQY-UHFFFAOYSA-N 2-[2-(4-phenylpiperazin-1-yl)ethyl]-3h-benzo[e]benzimidazole Chemical class N=1C2=CC=C3C=CC=CC3=C2NC=1CCN(CC1)CCN1C1=CC=CC=C1 KKAMJECDKNIUQY-UHFFFAOYSA-N 0.000 abstract 1
HCCNHYWZYYIOFM-UHFFFAOYSA-N 3h-benzo[e]benzimidazole Chemical class C1=CC=C2C(N=CN3)=C3C=CC2=C1 HCCNHYWZYYIOFM-UHFFFAOYSA-N 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
230000003276 anti-hypertensive effect Effects 0.000 abstract 1
-1 chloro, methoxy Chemical group 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
230000000144 pharmacologic effect Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Cardiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Heart & Thoracic Surgery (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

AT85100667T 1984-02-07 1985-01-23 Verwendung einiger 2-(2-(4-phenyl-1piperazinyl)|thyl>-1h-naphth-(1,2-d)imidazolderivate und deren pharmazeutisch annehmbare salze zur herstellung eines medikaments zur behandlung cardiovaskulaerer erkrankungen. ATE42548T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB848403141A GB8403141D0 (en)	1984-02-07	1984-02-07	Imidazole derivatives
EP85100667A EP0155459B1 (de)	1984-02-07	1985-01-23	Verwendung einiger 2-[2-(4-Phenyl-1-piperazinyl)äthyl]-1H-naphth-(1,2-d)imidazol-Derivate und deren pharmazeutisch annehmbare Salze zur Herstellung eines Medikaments zur Behandlung cardiovaskulärer Erkrankungen

Publications (1)

Publication Number	Publication Date
ATE42548T1 true ATE42548T1 (de)	1989-05-15

Family

ID=10556175

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT85100667T ATE42548T1 (de)	1984-02-07	1985-01-23	Verwendung einiger 2-(2-(4-phenyl-1piperazinyl)\|thyl>-1h-naphth-(1,2-d)imidazolderivate und deren pharmazeutisch annehmbare salze zur herstellung eines medikaments zur behandlung cardiovaskulaerer erkrankungen.

Country Status (8)

Country	Link
US (1)	US4594348A (de)
EP (1)	EP0155459B1 (de)
JP (1)	JPS60248613A (de)
AT (1)	ATE42548T1 (de)
CA (1)	CA1246455A (de)
DE (1)	DE3569733D1 (de)
GB (1)	GB8403141D0 (de)
ZA (1)	ZA85453B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US11173146B2 (en)	2014-04-25	2021-11-16	The Regents Of The University Of California	Selective activators of the intermediate conductance CA2+activated K+ channel KCa3.1 and their methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2964567D1 (en) *	1978-12-21	1983-02-24	Lepetit Spa	New 3h-naphtho(1,2-d)imidazoles, processes for preparing them, compounds for use as antiinflammatory and antimicrobial agents and compositions for that use containing them
EP0034249B1 (de) *	1980-02-08	1984-10-24	Gruppo Lepetit S.P.A.	Naphthimidazol- und Naphthoxazol-Derivate, ihre Herstellung und ihre Verwendung in Pharmazeutika
EP0034294A3 (de) *	1980-02-13	1982-07-07	Uniroyal, Inc.	Vulkanisierter Schlauch mit Verstärkungen für Klimaanlagen und Verfahren zu dessen Herstellung

1984
- 1984-02-07 GB GB848403141A patent/GB8403141D0/en active Pending
1985
- 1985-01-21 ZA ZA85453A patent/ZA85453B/xx unknown
- 1985-01-23 AT AT85100667T patent/ATE42548T1/de not_active IP Right Cessation
- 1985-01-23 DE DE8585100667T patent/DE3569733D1/de not_active Expired
- 1985-01-23 EP EP85100667A patent/EP0155459B1/de not_active Expired
- 1985-01-30 CA CA000473151A patent/CA1246455A/en not_active Expired
- 1985-02-06 US US06/698,653 patent/US4594348A/en not_active Expired - Fee Related
- 1985-02-06 JP JP60020161A patent/JPS60248613A/ja active Granted

Also Published As

Publication number	Publication date
ZA85453B (en)	1986-05-28
US4594348A (en)	1986-06-10
EP0155459B1 (de)	1989-04-26
DE3569733D1 (en)	1989-06-01
CA1246455A (en)	1988-12-13
GB8403141D0 (en)	1984-03-14
JPH0553775B2 (de)	1993-08-10
EP0155459A1 (de)	1985-09-25
JPS60248613A (ja)	1985-12-09

Similar Documents

Publication	Publication Date	Title
NO160439C (no)	1989-04-19	Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte imidazol-derivater.
ATE60761T1 (de)	1991-02-15	Chinazolinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
NO174772C (no)	1994-07-06	Analogifremgangsmåte ved fremstilling av terapeutisk aktive piperazinylderivater
NO166448C (no)	1991-07-24	Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner.
NO154089C (no)	1986-07-16	Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
ATE46164T1 (de)	1989-09-15	1,4:3,6-dianhydro-hexit-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
NO155884C (no)	1987-06-17	Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater.
ATE21246T1 (de)	1986-08-15	Substituierte imidazol-derivate mit pharmakologischer wirkung sowie ihre herstellung und verwendung.
ATE79257T1 (de)	1992-08-15	Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
DE3888340D1 (de)	1994-04-14	Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
NO881835L (no)	1988-10-31	Fremgangsmaate for fremstilling av terapeutisk aktive bicykliske forbindelser.
ATE42548T1 (de)	1989-05-15	Verwendung einiger 2-(2-(4-phenyl-1piperazinyl)\|thyl>-1h-naphth-(1,2-d)imidazolderivate und deren pharmazeutisch annehmbare salze zur herstellung eines medikaments zur behandlung cardiovaskulaerer erkrankungen.
ATE21101T1 (de)	1986-08-15	N-iminopyridinium-betain-derivate, ihre herstellung und ihre verwendung als arzneimittel.
NO883263D0 (no)	1988-07-22	Fremgangsmaate for fremstilling av terapeutisk aktive benzimidazol-derivater.
ATE56713T1 (de)	1990-10-15	1,2,3,4,4a,9b-hexahydro-4aaminoalkyldibenzofurane, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
US4140775A (en)	1979-02-20	Piperazino methyl phenyl aminoquinolines
ATE46147T1 (de)	1989-09-15	4-(nitrophenyl)-tetrahydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
NO844780L (no)	1985-06-04	Analogifremgangsmaate for fremstilling av terapeutisk aktive indolderivater
ES8500742A1 (es)	1984-11-01	Procedimiento para la preparacion de derivados de acido fenilacetico
DE69325462D1 (de)	1999-07-29	Verwendung von idazoxan und derivaten zur herstellung eines arzneimittels zur behandlung von parkinsonismus und seiner evolution
NO158462C (no)	1988-09-14	Analogifremgangsmaate for fremstilling av terapeutisk aktive (1,2)-kondenserte 1,4-benzodiazepinforbindelser.
KR900004730A (ko)	1990-04-12	정신병 치료제인 4-[4-(3-벤즈이소티아졸릴)-1-피페라지닐]부틸 가교결합된 이환상 이미드
JPH0253722A (ja)	1990-02-22	アジョエン及びアジョエン誘導体の細胞活性静止物質及び／又は細胞毒性物質として、又は細胞活性静止作用及び／又は細胞毒性作用における使用及びそれらの化合物を含有する薬剤
DE3782229D1 (de)	1992-11-19	Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.

Legal Events

Date	Code	Title	Description
1989-10-15	UEP	Publication of translation of european patent specification
1994-10-15	REN	Ceased due to non-payment of the annual fee